Ethics, Equity & Informed Consent

Belmont & Helsinki in Practice: Turning First Principles into Inspection-Ready Research Conduct

Posted on By digi

Belmont & Helsinki in Practice: Turning First Principles into Inspection-Ready Research Conduct Applying Belmont Principles and the Declaration of Helsinki to Design, Consent, and Oversight First Principles: Belmont’s Ethic and Helsinki’s Clinical Covenant Modern clinical research rests on two enduring foundations. The Belmont Report articulates three normative pillars—Respect for Persons, Beneficence, and Justice—that frame how…

Read More “Belmont & Helsinki in Practice: Turning First Principles into Inspection-Ready Research Conduct” »

Belmont Principles & Declaration of Helsinki, Ethics, Equity & Informed Consent

Ethics, Equity, and Informed Consent in Clinical Research — Protecting Participants and Building Public Trust

Posted on By digi

Ethics, Equity, and Informed Consent in Clinical Research — Protecting Participants and Building Public Trust Informed Consent in Clinical Research: Protecting Participants While Ensuring Ethical Equity Clinical research is built upon an ethical foundation that ensures human dignity, respect, and justice. Every clinical trial must protect participants’ rights, prioritize safety, and ensure that the pursuit…

Read More “Ethics, Equity, and Informed Consent in Clinical Research — Protecting Participants and Building Public Trust” »

Ethics, Equity & Informed Consent

IRB/IEC Submission & Continuing Review: A Sponsor’s Playbook for Ethics Approval and Ongoing Oversight

Posted on By digi

IRB/IEC Submission & Continuing Review: A Sponsor’s Playbook for Ethics Approval and Ongoing Oversight From First Approval to Renewal: Mastering IRB/IEC Submissions and Continuing Review What Ethics Committees Expect: Scope, Roles, and Regulatory Interfaces Institutional Review Boards (IRBs) and Independent Ethics Committees (IECs) evaluate whether a clinical investigation protects participants’ rights, safety, and welfare and…

Read More “IRB/IEC Submission & Continuing Review: A Sponsor’s Playbook for Ethics Approval and Ongoing Oversight” »

Ethics, Equity & Informed Consent, IRB/IEC Submission & Continuing Review

Informed Consent That Stands Up to Inspection: Design, Execution, and Documentation for Modern Trials

Posted on By digi

Informed Consent That Stands Up to Inspection: Design, Execution, and Documentation for Modern Trials Building, Delivering, and Recording Informed Consent in Clinical Research Consent That Works: Purpose, Legal Interfaces, and Who Does What What informed consent really is. Informed consent is a conversation plus documentation that demonstrates a person (or their legally acceptable representative, LAR)…

Read More “Informed Consent That Stands Up to Inspection: Design, Execution, and Documentation for Modern Trials” »

Ethics, Equity & Informed Consent, Informed Consent Process & Documentation

Safeguarding Vulnerable Participants: Operational Guidance for Pediatric, Cognitively Impaired, and Prisoner-Involved Trials

Posted on By digi

Safeguarding Vulnerable Participants: Operational Guidance for Pediatric, Cognitively Impaired, and Prisoner-Involved Trials Ethical Operations for Children, Adults with Impaired Capacity, and Incarcerated Participants Defining Vulnerability and Translating It into Practical Protections “Vulnerable populations” is a regulatory shorthand for participants who—because of age, cognitive status, environment, or constrained liberty—may face elevated risks of misunderstanding, coercion, or…

Read More “Safeguarding Vulnerable Participants: Operational Guidance for Pediatric, Cognitively Impaired, and Prisoner-Involved Trials” »

Ethics, Equity & Informed Consent, Vulnerable Populations (Pediatrics, Cognitively Impaired, Prisoners)

Cultural Competence & Health Literacy in Clinical Trials: Designing Materials, Workflows, and Oversight That Truly Include Everyone

Posted on By digi

Cultural Competence & Health Literacy in Clinical Trials: Designing Materials, Workflows, and Oversight That Truly Include Everyone Operationalizing Culture and Literacy: Practical Steps to Make Studies Understandable, Respectful, and Compliant Why Culture and Literacy Determine Trial Success: People, Contexts, and Regulatory Expectations Every protocol lives or dies on comprehension and trust. Cultural norms shape how…

Read More “Cultural Competence & Health Literacy in Clinical Trials: Designing Materials, Workflows, and Oversight That Truly Include Everyone” »

Cultural Competence & Health Literacy, Ethics, Equity & Informed Consent

Language Access & Translations in Clinical Trials: A Compliance-First Guide to Multilingual Consent and Communication

Posted on By digi

Language Access & Translations in Clinical Trials: A Compliance-First Guide to Multilingual Consent and Communication Designing and Documenting Language Access for Ethical, Inspection-Ready Clinical Research Why Language Access Is Compliance-Critical: Ethics, Law, and Agency Expectations Language access is not a courtesy—it’s a core control for protecting participant rights, safety, and data integrity. When people with…

Read More “Language Access & Translations in Clinical Trials: A Compliance-First Guide to Multilingual Consent and Communication” »

Ethics, Equity & Informed Consent, Language Access & Translations

Equity in Recruitment & Fair Participant Selection: A Compliance-First Playbook for Representative Clinical Trials

Posted on By digi

Equity in Recruitment & Fair Participant Selection: A Compliance-First Playbook for Representative Clinical Trials Designing Fair Selection and Equitable Recruitment That Withstand Inspection What “Fair Selection” Really Means: Ethics, Regulations, and Scientific Rigor Fair participant selection is more than a moral aspiration; it is a regulatory and scientific necessity. Ethically, it derives from Belmont’s principle…

Read More “Equity in Recruitment & Fair Participant Selection: A Compliance-First Playbook for Representative Clinical Trials” »

Equity in Recruitment & Fair Participant Selection, Ethics, Equity & Informed Consent

Compensation, Reimbursement & Undue Influence: Engineering Ethical Payments in Clinical Trials

Posted on By digi

Compensation, Reimbursement & Undue Influence: Engineering Ethical Payments in Clinical Trials Designing Participant Payments That Are Fair, Transparent, and Inspection-Ready Payments in Research—Ethical Foundations, Definitions, and Red Lines Why payments matter. Money and material benefits can enable participation (e.g., transport, childcare) or distort it. Ethical research must reduce barriers without creating pressure that leads people…

Read More “Compensation, Reimbursement & Undue Influence: Engineering Ethical Payments in Clinical Trials” »

Compensation, Reimbursement & Undue Influence, Ethics, Equity & Informed Consent

Community Engagement & Public Trust in Clinical Trials: From First Contact to Last Result

Posted on By digi

Community Engagement & Public Trust in Clinical Trials: From First Contact to Last Result Earning and Sustaining Public Trust through Meaningful Community Engagement Why Trust Is a Prerequisite, Not a Perk Every successful clinical program rests on an invisible asset—public trust. Without it, recruitment stalls, adherence wobbles, safety signals go unreported, and the social license…

Read More “Community Engagement & Public Trust in Clinical Trials: From First Contact to Last Result” »

Community Engagement & Public Trust, Ethics, Equity & Informed Consent